UC Davis, TargaGenix, Northeastern University receive $3M R01 grant to study pancreatic cancer

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

A partnership between UC Davis Comprehensive Cancer Center, TargaGenix, and Northeastern University will receive nearly $3 million over five years to study pancreatic ductal adenocarcinoma through an NIH R01 grant. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Table of Contents

YOU MAY BE INTERESTED IN

Login